All sponsors

Shanghai Mabgeek Biotech.Co.Ltd

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS11
PHASE 3 / 2-37
RECRUITING4
READOUTS ≤12 MONTHS2
Open Shanghai Mabgeek Biotech.Co.Ltd on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
MG-K10
NCT06765005
P1/2RecruitingAtopic Dermatitis242025-05
MG-K10 Humanized Monoclonal Antibody Injection
NCT06846385
P2/3RecruitingSeasonal Allergic Rhinitis1602025-05-31
MG-ZG122 Humanized Monoclonal Antibody Injection
NCT07054034
P2Active, not recruitingBronchial Asthma1602026-05-26
NCT06779136
NCT06779136
P3RecruitingPrurigo Nodularis1602026-08 (+1 mo)
MG-K10 Injection (Humanized Monoclonal Antibody)
NCT07540442
P3Not yet recruitingDermatitis, Atopic1802027-01-05
MG-K10 Injection
NCT07838727
P2Not yet recruitingChronic Urticaria, Idiopathic602027-05-07
NCT06837922
NCT06837922
P3RecruitingAsthma5042027-11-15 (+5 mo)
Emollient (moisturizer)
NCT07938606
P1/2Not yet recruitingAtopic Dermatitis242027-12
MG-K10
NCT07903194
P3Not yet recruitingChronic Rhinosinusitis With Nasal Polyps2102027-12-21
MG-K10 Humanized Monoclonal Antibody Injection
NCT07546487
P3Not yet recruitingChronic Spontaneous Urticaria (CSU)2262028-03-31
ADaggio
NCT07479615
P3Not yet recruitingAtopic Dermatitis; Atopic Eczema4982029-01